Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
HDFC Pharma And Healthcare Fund Growth
NAV: 16 Sep '26
₹21.44
Min. for SIP
₹100
Fund size (AUM)
₹3,310.64 Cr
Expense ratio
2.11%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,175 | +1.17% | |
| 6 months | ₹30,000 | ₹32,455 | +8.18% | |
| 1 year | ₹60,000 | ₹69,516 | +15.86% |
Holdings (41)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | Equity | 9.54% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.94% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.08% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.06% |
| Lupin Ltd | Healthcare | Equity | 4.04% |
| Cipla Ltd | Healthcare | Equity | 3.94% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.84% |
| Neuland Laboratories Ltd | Healthcare | Equity | 3.70% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 3.48% |
| Ami Organics Ltd | Healthcare | Equity | 3.24% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.23% |
| Shilpa Medicare Ltd | Healthcare | Equity | 3.10% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.06% |
| Global Health Ltd | Healthcare | Equity | 2.85% |
| Rubicon Research Ltd. | Healthcare | Equity | 2.82% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.37% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 2.34% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 2.25% |
| Vijaya Diagnostic Centre Ltd | Healthcare | Equity | 2.24% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 1.94% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.93% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 1.90% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 1.90% |
| Repo | Unspecified | Repo | 1.83% |
| Molbio Diagnostics Ltd. | Healthcare | Equity | 1.77% |
| Biocon Ltd | Healthcare | Equity | 1.73% |
| Wockhardt Ltd | Healthcare | Equity | 1.61% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 1.60% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 1.39% |
| Thyrocare Technologies Ltd | Healthcare | Equity | 1.31% |
| Symbiotec Pharmalab Ltd. | Healthcare | Equity | 1.21% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.18% |
| Gland Pharma Ltd | Healthcare | Equity | 1.09% |
| CORONA Remedies Ltd. | Healthcare | Equity | 1.07% |
| Eris Lifesciences Ltd | Healthcare | Equity | 1.06% |
| Jubilant Pharmova Ltd | Healthcare | Equity | 0.85% |
| Bajaj Healthcare Ltd | Healthcare | Equity | 0.57% |
| Novartis India Ltd | Healthcare | Equity | 0.47% |
| Laxmi Dental Ltd. | Healthcare | Equity | 0.38% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 0.34% |
| Net Payables | Unspecified | Net Payables | -0.25% |
See All
Minimum investments
Min. for 1st investment
₹100
Min. for 2nd investment
₹100
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +12.3% | +24.5% | +26.0% | +119.4% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 4 | 3 | 2 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 1%, if redeemed within 30 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
DMDhruv MuchhalSep 2023 - PresentView details
DM
Dhruv Muchhal
Sep 2023 - Present
View details
NMNikhil MathurSep 2023 - PresentView details
NM
Nikhil Mathur
Sep 2023 - Present
View details
About HDFC Pharma And Healthcare Fund Growth
HDFC Pharma And Healthcare Fund Growth is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 10 Dec 1999. Dhruv Muchhal is the Current Fund Manager of HDFC Pharma And Healthcare Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹9,86,237 Cr and the Latest NAV as of 16 Sep 2026 is ₹21.44.
The HDFC Pharma And Healthcare Fund Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100. Exit load of 1%, if redeemed within 30 days.
;
Investment Objective
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#2 in India
Total AUM₹9,86,236.84 Cr
Date of Incorporation10 Dec 1999
Launch Date10 Dec 1999
Address"HDFC House", 2nd Floor, H. T. Parekh Marg, 165-166, BackbayReclamation, Churchgate Mumbai 400020
CustodianHongkong & Shanghai Banking Corporation
Registrar & Transfer AgentCams
Email[email protected]
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,